These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24066117)

  • 21. Gene expression profile of trisomy 21 placentas: a potential approach for designing noninvasive techniques of prenatal diagnosis.
    Gross SJ; Ferreira JC; Morrow B; Dar P; Funke B; Khabele D; Merkatz I
    Am J Obstet Gynecol; 2002 Aug; 187(2):457-62. PubMed ID: 12193943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid prenatal diagnosis of trisomy 21 by polymerase chain reaction- associated analysis of small tandem repeats and S100B in chromosome 21.
    Yang YH; Kim IK; Oh SH; Kim CK; Kim JY
    Fetal Diagn Ther; 1998; 13(6):361-6. PubMed ID: 9933820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex.
    Koumbaris G; Kypri E; Tsangaras K; Achilleos A; Mina P; Neofytou M; Velissariou V; Christopoulou G; Kallikas I; González-Liñán A; Benusiene E; Latos-Bielenska A; Marek P; Santana A; Nagy N; Széll M; Laudanski P; Papageorgiou EA; Ioannides M; Patsalis PC
    Clin Chem; 2016 Jun; 62(6):848-55. PubMed ID: 27117469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
    Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
    Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study.
    El Khattabi LA; Rouillac-Le Sciellour C; Le Tessier D; Luscan A; Coustier A; Porcher R; Bhouri R; Nectoux J; Sérazin V; Quibel T; Mandelbrot L; Tsatsaris V; Vialard F; Dupont JM
    PLoS One; 2016; 11(5):e0155009. PubMed ID: 27167625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of sensitivity and specificity of a novel gene dosage assay for prenatal screening of trisomy 21 syndrome.
    Kamyab AR; Shahrokhi F; Shamsian E; Hayat Nosaied M; Dibajnia P; Hashemi M; Mahdian R
    Clin Biochem; 2012 Feb; 45(3):267-71. PubMed ID: 22178108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithms.
    Stumm M; Entezami M; Trunk N; Beck M; Löcherbach J; Wegner RD; Hagen A; Becker R; Hofmann W
    Prenat Diagn; 2012 Jun; 32(6):569-77. PubMed ID: 22573401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of the BACs-on-Beads™ assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series.
    Choy KW; Kwok YK; Cheng YK; Wong KM; Wong HK; Leung KO; Suen KW; Adler K; Wang CC; Lau TK; Schermer MJ; Lao TT; Leung TY
    BJOG; 2014 Sep; 121(10):1245-52. PubMed ID: 24893808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
    Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific transcriptional changes in human fetuses with autosomal trisomies.
    Altug-Teber O; Bonin M; Walter M; Mau-Holzmann UA; Dufke A; Stappert H; Tekesin I; Heilbronner H; Nieselt K; Riess O
    Cytogenet Genome Res; 2007; 119(3-4):171-84. PubMed ID: 18253026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.
    Lim JH; Lee DE; Kim SY; Kim HJ; Kim KS; Han YJ; Kim MH; Choi JS; Kim MY; Ryu HM; Park SY
    J Assist Reprod Genet; 2015 May; 32(5):827-37. PubMed ID: 25749789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Noninvasive prenatal screen of trisomy-21 using maternal plasma fetal free RNA allelic ratio].
    Xu Y; Zhai S; Luo X; Zhang Y; Ran L; Ren L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):568-75. PubMed ID: 26675178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflex antenatal DNA screening for Down syndrome.
    Wald NJ; Huttly WJ; Bestwick JP; Aquilina J; Peregrine E
    Prenat Diagn; 2015 Nov; 35(11):1154. PubMed ID: 26211510
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular detection of trisomy 21 by bicolor competitive fluorescent PCR.
    Wang Y; Zhang X; Ling B; He C; Xia Q; Chen F; Miyamori I; Yang Z; Fan C
    J Clin Lab Anal; 2013 May; 27(3):245-8. PubMed ID: 23686780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
    Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
    Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.
    Go AT; Visser A; Mulders MA; Twisk JW; Blankenstein MA; van Vugt JM; Oudejans CB
    Prenat Diagn; 2007 Feb; 27(2):146-9. PubMed ID: 17186567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.